Mohammed H. AL Mughram

Dr. Mohammed H. AL Mughram

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2024 in Applied Organometallic Chemistry
Verified
Journal Article
Closed access
MRMahmoud El Remaily
Mahmoud El Remaily
TEThomas Nady A. Eskander
Thomas Nady A. Eskander
AAAbdullah Yahya Abdullah Alzahrani
Abdullah Yahya Abdullah Alzahrani
MAMosa Alsehli
Mosa Alsehli
KAKhalaf Al‐Ghamdi
Khalaf Al‐Ghamdi
AAAhmed M. Abu‐Dief
Ahmed M. Abu‐Dief

Verified
Journal Article
Open access
PDF file
MMMohammed H. AL Mughram
Mohammed H. AL Mughram
MGMohini S. Ghatge
Mohini S. Ghatge
GKGlen Kellogg
Glen Kellogg
Martin SafoMartin Safo
Martin Safo
Pyridoxal 5′-phosphate (PLP), the active form of vitamin B6, serves as a cofactor for scores of B6-dependent (PLP-dependent) enzymes involved in many cellular processes. One such B6 enzyme is dopa decarboxylase (DDC), which is required for the biosynthesis of key neurotransmitters, e.g., dopamine and serotonin. PLP-dependent enzymes are biosynthesized as apo-B6 enzymes and then converted to the catalytically active holo-B6 enzymes by Schiff base formation between the aldehyde of PLP and an active site lysine of the protein. In eukaryotes, PLP is made available to the B6 enzymes through the activity of the B6-salvage enzymes, pyridoxine 5′-phosphate oxidase (PNPO) and pyridoxal kinase (PLK). To minimize toxicity, the cell keeps the content of free PLP (unbound) very low through dephosphorylation and PLP feedback inhibition of PNPO and PLK. This has led to a proposed mechanism of complex formation between the B6-salvage enzymes and apo-B6 enzymes prior to the transfer of PLP, although such complexes are yet to be characterized at the atomic level, presumably due to their transient nature. A computational study, for the first time, was used to predict a likely PNPO and DDC complex, which suggested contact between the allosteric PLP tight-binding site on PNPO and the active site of DDC. Using isothermal calorimetry and/or surface plasmon resonance, we also show that PNPO binds both apoDDC and holoDDC with dissociation constants of 0.93 ± 0.07 μM and 2.59 ± 0.11 μM, respectively. Finally, in the presence of apoDDC, the tightly bound PLP on PNPO is transferred to apoDDC, resulting in the formation of about 35% holoDDC.

19 December 2023 in Molecules
Verified
Journal Article
Open access
PDF file
Abdelmoujoud FarisAbdelmoujoud Faris
Abdelmoujoud Faris
Radwan ِAlnajjarRadwan ِAlnajjar
Radwan ِAlnajjar
Jingjing GuoJingjing Guo
Jingjing Guo
MMMohammed H. AL Mughram
Mohammed H. AL Mughram
AAAdnane Aouidate
Adnane Aouidate
MEMenana Elhallaoui
Menana Elhallaoui
This work aimed to find new inhibitors of the CYP3A4 and JAK3 enzymes, which are significant players in autoimmune diseases such as rheumatoid arthritis. Advanced computer-aided drug design techniques, such as pharmacophore and 3D-QSAR modeling, were used. Two strong 3D-QSAR models were created, and their predictive power was validated by the strong correlation (R2 values > 80%) between the predicted and experimental activity. With an ROC value of 0.9, a pharmacophore model grounded in the DHRRR hypothesis likewise demonstrated strong predictive ability. Eight possible inhibitors were found, and six new inhibitors were designed in silico using these computational models. The pharmacokinetic and safety characteristics of these candidates were thoroughly assessed. The possible interactions between the inhibitors and the target enzymes were made clear via molecular docking. Furthermore, MM/GBSA computations and molecular dynamics simulations offered insightful information about the stability of the binding between inhibitors and CYP3A4 or JAK3. Through the integration of various computational approaches, this study successfully identified potential inhibitor candidates for additional investigation and efficiently screened compounds. The findings contribute to our knowledge of enzyme–inhibitor interactions and may help us create more effective treatments for autoimmune conditions like rheumatoid arthritis.

17 December 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MRMahmoud El Remaily
Mahmoud El Remaily
TEThomas Nady A. Eskander
Thomas Nady A. Eskander
AAAbdullah A H Alzahrani
Abdullah A H Alzahrani
MMMohammed H. AL Mughram
Mohammed H. AL Mughram
OEOmar M. Elhady
Omar M. Elhady
Ahmed Abu-Dief MohammedAhmed Abu-Dief Mohammed
Ahmed Abu-Dief Mohammed
Three innovative Pd(II) complexes were synthesized through the reaction of Pd(II)ions with thiazole ligands: BZU, BIU, and BTU. These complexes, along with their ligands, were characterized using a diverse set of analytical methods, including infrared spectroscopy, 1H and 13C NMR spectroscopy, X-ray diffraction, UV-visible spectroscopy, CHN elemental analysis, mass spectrometry, thermogravimetric analysis, and magnetic susceptibility tests. The results indicated that the structures of BZU-Pd, BIU-Pd, and BTU-Pd complexes are square planar. To explore their catalytic properties, the thiazole-based complexes were tested in a four-component condensation reaction under mild and eco-friendly conditions. The study systematically assessed the effects of various catalyst types, such asLewisacids, bases, and ionic liquids, as well as the influence of solvent choice and catalyst concentration. Optimal conditions revealed that all catalysts exhibited notable catalytic effectiveness, with high turnover frequency (TOF) values showcasing their ability to efficiently produce 6-(pyrrolidin-1-yl)-[1,5-a] thiazolo [4,5-d] pyrimidine derivatives. Moreover, the three catalysts retained their efficiency throughout the reaction, with the first catalyst maintaining its effectiveness for eight cycles, while the other two catalysts preserved their efficiency for six cycles each. This method, characterized by its simplicity, safety, stability of the catalysts, rapid reaction times, and high product yields, presents significant promise for future applications in industry.

30 November 2021 in Journal of Structural Biology: X
Verified
Journal Article
Open access
MMMohammed H. AL Mughram
Mohammed H. AL Mughram
NHNoah Herrington
Noah Herrington
CCClaudio Catalano
Claudio Catalano
GKGlen Kellogg
Glen Kellogg
• The relative populations of residue types are shown for soluble and membrane proteins. • Populations within secondary structure bins vary with residue and protein solubility. • Solvent accessible surface area depends on secondary structure and protein solubility. • More exposed hydrophobic residues interact favorably with lipids in membrane proteins. • More buried polar residues make more hydrogen bonds within protein interiors.

23 September 2025 in Archiv der Pharmazie
Verified
Journal Article
Closed access
Mahmood AhmedMahmood Ahmed
Mahmood Ahmed
MMMuhammad Zaeem Mehdi
Muhammad Zaeem Mehdi
MJMehwish Javed
Mehwish Javed
MMMohammed H. AL Mughram
Mohammed H. AL Mughram
MIMasooma Irfan
Masooma Irfan
Ali Abbas AslamAli Abbas Aslam
Ali Abbas Aslam